Testing effectiveness (Phase 2)Not Yet RecruitingNCT07634601
What this trial is testing
Elacestrant With Everolimus for the Treatment of Recurrent Advanced or Metastatic ER-Positive Endometrial Cancer
Who this might be right for
Advanced Endometrial CarcinomaMetastatic Endometrial CarcinomaRecurrent Endometrial Carcinoma+2 more
Jonsson Comprehensive Cancer Center 50